Want to join the conversation?
$GGP 2Q15 Call: 3Q15 Outlook: We expect same-store NOI of approx. $555MM or 4.25-4.5% growth. We expect net G&A of approx. $43MM and expect 4-4.5% EBITDA growth of approx. $520MM. We expect financing cost to be around $205MM and FFO in the range of $325-335MM or FFO per share of $0.34-0.36, representing growth of approx. 7.5% per share.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?